Holding(s) in Company

RNS Number : 5632S
Proteome Sciences PLC
03 December 2012
 






TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

PROTEOME SCIENCES PLC (LN*)

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YES

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):



3. Full name of person(s) subject to the
notification obligation:
iii

VULPES LIFE SCIENCES FUND

4. Full name of shareholder(s)
 (if different from 3.):iv


5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

26 Nov 2012

6. Date on which issuer notified:

29 Nov 2012

7. Threshold(s) that is/are crossed or
reached:
vi, vii

16.98%



 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0003104196

32,816,957

32,816,957

32,625,000

32,625,000


16.95%




B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights







C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 





 

 

Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

32,625,000

16.95%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

 

 


Proxy Voting:

10. Name of the proxy holder:


11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:




13. Additional information:



14. Contact name:


15. Contact telephone number:




 

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in share


A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

 

VULPES LIFE SCIENCES FUND

Contact address

(registered office for legal entities)

 

c/o MAPLES CORPORATE SERVICES LIMITED, PO BOX 309, UGLAND HOUSE, GRAND CAYMAN,        KY1-1104, CAYMAN ISLANDS

Phone number & email

 


Other useful information

(at least legal representative for legal persons)

 




B: Identity of the notifier, if applicable

Full name

 

STEPHEN LUKOW

Contact address

 

2 BATTERY ROAD #26-01 MAYBANK TOWER SINGAPORE 049907

Phone number & email

 

TEL: (65) 6538 1998

Email: chvaluation@vulpesinvest.com

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

CHIEF OPERATING OFFICER AND LEGAL COUNSEL


C: Additional information

Email address: Complete the required TR-1 form and email it to: Major shareholdings majorshareholdings@fsa.gov.uk
Fax number: You can print the
TR-1 form, complete it and fax it to: 020 7066 0050

For notes on how to complete form TR-1 please see the FSA website.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUGGCUPUPPGGW
UK 100

Latest directors dealings